IMPACT OF MAINTENANCE THERAPY WITH LOW-DOSE GLUCOCORTICOIDS IN PATIENTS UNDERGOING BIOLOGICAL AND TARGETED SYNTHETIC DMARDS FOR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Giollo, A. [1 ]
Zen, M. [1 ]
Salvato, M. [1 ]
Frizzera, F. [1 ]
Botsios, K. [1 ]
Ramonda, R. [1 ]
Doria, A. [1 ]
机构：
[1] Univ Padua, Rheumatol Unit, Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
D O I：
10.1136/annrheumdis-2023-eular.456
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0460
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [21] LOW-DOSE PREDNISOLONE THERAPY IN RHEUMATOID-ARTHRITIS
    BAUMANN, M
    ZEIDLER, H
    RAU, R
    STROEHMANN, I
    WARNATZ, H
    AKTUELLE RHEUMATOLOGIE, 1993, 18 (02) : 62 - 68
  • [22] COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs
    Tsai, Jih-Jin
    Liu, Li-Teh
    Chen, Chun-Hong
    Chen, Liang-Jen
    Wang, Shiow-Ing
    Wei, James Cheng-Chung
    RMD OPEN, 2023, 9 (03):
  • [23] Early rheumatoid arthritis: combination therapy with disease-modifying antirheumatic drugs and low-dose glucocorticoids?
    John Kirwan
    Nature Clinical Practice Rheumatology, 2006, 2 (4): : 182 - 183
  • [24] Biological/targeted synthetic DMARDs do not arrest bone loss in patients with rheumatoid arthritis: a multicenter prospective observational study
    Sonomoto, Koshiro
    Nakayamada, Shingo
    Fujino, Yoshihisa
    Miyata, Hiroko
    Kubo, Satoshi
    Fujita, Yuya
    Inoue, Yoshino
    Matsunaga, Satsuki
    Iwata, Shigeru
    Hanami, Kentaro
    Todoroki, Yasuyuki
    Yoshinari-Korekoda, Hiroko
    Kawabe, Akio
    Yamaguchi, Ayako
    Ueno, Masanobu
    Satoh-Kanda, Yurie
    Kanda, Ryuichiro
    Funada, Masashi
    Ohkubo, Naoaki
    Kusaka, Katsuhide
    Kosaka, Shumpei
    Nagayasu, Atsushi
    Fukuyo, Shunsuke
    Nawata, Masao
    Miyazaki, Yusuke
    Tokunaga, Mikiko
    Tanaka, Kenichi
    Okada, Yosuke
    Tanaka, Yoshiya
    RHEUMATOLOGY, 2023, 63 (08) : 2239 - 2248
  • [25] Rethinking the Balance of Risks and Rewards of Chronic Low-Dose Glucocorticoids in Rheumatoid Arthritis
    Orange, Dana E.
    Mehta, Bella
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (11) : 933 - +
  • [26] Etoricoxib is efficacious in patients with rheumatoid arthritis (RA) on concomitant therapy with disease modifying antirheumatic drulis (DMARDs), and/or low-dose corticosteroids.
    Matsumoto, A
    Zhao, PL
    Cichanowitz, N
    Melian, A
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S123 - S123
  • [27] FOLATE STATUS OF RHEUMATOID-ARTHRITIS PATIENTS ON LOW-DOSE METHOTREXATE THERAPY
    MORGAN, SL
    BAGGOTT, JE
    ALTZSMITH, M
    CLINICAL RESEARCH, 1987, 35 (03): : A777 - A777
  • [28] Influence of low-dose prednisolone therapy on DMARD survival in patients with rheumatoid arthritis
    Malysheva, O.
    Wahle, M.
    Wahle, M.
    Wagner, U.
    Pierer, M.
    Arnold, S.
    Haentzschel, H.
    Baerwald, C. G. O.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 445 - 445
  • [29] Influence of low-dose prednisolone therapy on DMARD survival in patients with rheumatoid arthritis
    Malysheva, O. A.
    Wahle, M.
    Wagner, U.
    Pierer, M.
    Arnold, S.
    Hantzschel, H.
    Baerwald, C. G. O.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2007, 66 : 79 - 79
  • [30] FOLATE STATUS OF RHEUMATOID-ARTHRITIS PATIENTS ON LOW-DOSE METHOTREXATE THERAPY
    MORGAN, SL
    BAGGOTT, JE
    ALTZSMITH, M
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1987, 45 (04): : 848 - 848
12345